Tarsa Therapeutics, Inc. announced it raised $1.25 Million in an initial filing from an offering of $1.25 Million

Jul 14, 2016•almost 9 years ago

Amount Raised

$1.25 Million

Round Type

seed

PhiladelphiaBiotechnology

Company Information

Company

Tarsa Therapeutics, Inc.

Location

8 Penn Center, 1628 JFK Blvd Suite 1400

Philadelphia, Pennsylvania, United States

About

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.

Medium Activity

Get personalized insights on buying likelihood